Chemed Corp Files DEF 14A with Executive Compensation Details
Ticker: CHE · Form: DEF 14A · Filed: Apr 8, 2024 · CIK: 19584
| Field | Detail |
|---|---|
| Company | Chemed Corp (CHE) |
| Form Type | DEF 14A |
| Filed Date | Apr 8, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $1, $5.0 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: DEF 14A, Chemed Corp, Executive Compensation, Stock Awards, Pension Values
TL;DR
<b>Chemed Corp's DEF 14A filing details executive compensation, including stock awards and pension values for the 2023 fiscal year.</b>
AI Summary
CHEMED CORP (CHE) filed a Proxy Statement (DEF 14A) with the SEC on April 8, 2024. Chemed Corp filed a DEF 14A on April 8, 2024. The filing covers the fiscal year ending December 31, 2023. It includes details on stock options and stock awards granted to PEO and Non-PEO members. Information on prior year stock option and award fair values is provided. Pension-related actuarial values and service costs are also detailed for PEO and Non-PEO members.
Why It Matters
For investors and stakeholders tracking CHEMED CORP, this filing contains several important signals. This filing provides transparency into the executive compensation structure, which can influence investor perception and executive decision-making. Understanding the details of stock options, awards, and pension values is crucial for shareholders evaluating the company's long-term incentive alignment and financial health.
Risk Assessment
Risk Level: low — CHEMED CORP shows low risk based on this filing. The filing is a standard DEF 14A, providing routine disclosure of executive compensation and corporate governance information, with no immediate red flags.
Analyst Insight
Review the detailed executive compensation breakdown to assess alignment with company performance and shareholder interests.
Key Numbers
- 2023-01-01 — Fiscal Year Start (PEO Member Stock Options)
- 2023-12-31 — Fiscal Year End (PEO Member Stock Options)
- 2022-01-01 — Fiscal Year Start (PEO Member Stock Options)
- 2022-12-31 — Fiscal Year End (PEO Member Stock Options)
Key Players & Entities
- CHEMED CORP (company) — Filer name
- 2024-04-08 (date) — Filing date
- 2023-12-31 (date) — Fiscal year end
- 2022-12-31 (date) — Prior fiscal year end
- 2021-12-31 (date) — Prior fiscal year end
- 2020-12-31 (date) — Prior fiscal year end
FAQ
When did CHEMED CORP file this DEF 14A?
CHEMED CORP filed this Proxy Statement (DEF 14A) with the SEC on April 8, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by CHEMED CORP (CHE).
Where can I read the original DEF 14A filing from CHEMED CORP?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by CHEMED CORP.
What are the key takeaways from CHEMED CORP's DEF 14A?
CHEMED CORP filed this DEF 14A on April 8, 2024. Key takeaways: Chemed Corp filed a DEF 14A on April 8, 2024.. The filing covers the fiscal year ending December 31, 2023.. It includes details on stock options and stock awards granted to PEO and Non-PEO members..
Is CHEMED CORP a risky investment based on this filing?
Based on this DEF 14A, CHEMED CORP presents a relatively low-risk profile. The filing is a standard DEF 14A, providing routine disclosure of executive compensation and corporate governance information, with no immediate red flags.
What should investors do after reading CHEMED CORP's DEF 14A?
Review the detailed executive compensation breakdown to assess alignment with company performance and shareholder interests. The overall sentiment from this filing is neutral.
How does CHEMED CORP compare to its industry peers?
Chemed Corp operates in the home health care services and industrial applications sectors. This filing is a proxy statement related to executive compensation.
Are there regulatory concerns for CHEMED CORP?
The DEF 14A filing is a requirement under the Securities Exchange Act of 1934, mandating public companies to provide detailed information to shareholders regarding corporate governance and executive compensation.
Industry Context
Chemed Corp operates in the home health care services and industrial applications sectors. This filing is a proxy statement related to executive compensation.
Regulatory Implications
The DEF 14A filing is a requirement under the Securities Exchange Act of 1934, mandating public companies to provide detailed information to shareholders regarding corporate governance and executive compensation.
What Investors Should Do
- Analyze the compensation packages for named executive officers.
- Compare stock option and award values year-over-year.
- Review pension-related disclosures for potential long-term liabilities.
Key Dates
- 2024-04-08: Filing Date — Submission of DEF 14A
- 2023-12-31: Fiscal Year End — Period covered by compensation details
Year-Over-Year Comparison
This filing is a DEF 14A, which is a routine disclosure. Specific financial performance data for the prior year is not directly presented in this excerpt, but compensation details are compared across years.
Filing Stats: 4,702 words · 19 min read · ~16 pages · Grade level 12.7 · Accepted 2024-04-08 10:00:40
Key Financial Figures
- $1 — ,319 shares of capital stock, par value $1 per share ("Capital Stock"), entitled t
- $5.0 billion — th oversight responsibility for Grace's $5.0 billion global supply chain. He is currently Pr
Filing Documents
- che-20240408xdef14a.htm (DEF 14A) — 2967KB
- che-20240408xdef14ag001.jpg (GRAPHIC) — 1KB
- che-20240408xdef14ag002.jpg (GRAPHIC) — 1KB
- che-20240408xdef14ag003.jpg (GRAPHIC) — 18KB
- che-20240408xdef14ag004.jpg (GRAPHIC) — 42KB
- che-20240408xdef14ag005.jpg (GRAPHIC) — 132KB
- che-20240408xdef14ag006.jpg (GRAPHIC) — 10KB
- che-20240408xdef14ag007.jpg (GRAPHIC) — 84KB
- che-20240408xdef14ag008.jpg (GRAPHIC) — 13KB
- che-20240408xdef14ag009.jpg (GRAPHIC) — 49KB
- 0001562762-24-000082.txt ( ) — 4940KB
- che-20240408.xsd (EX-101.SCH) — 6KB
- che-20240408_def.xml (EX-101.DEF) — 5KB
- che-20240408_lab.xml (EX-101.LAB) — 47KB
- che-20240408_pre.xml (EX-101.PRE) — 21KB
- che-20240408xdef14a_htm.xml (XML) — 394KB
Executive Compensation Consultant, Independence
Executive Compensation Consultant, Independence 15 Peer Group 16 Base Salaries 17 Annual Non Equity Incentive Compensation 17 One-Time Special Cash Incentive 19 Long-Term Incentives 20 Retirement Benefits 22 Tax Considerations 23 Employment Agreements 23 Stock Ownership Guidelines 25 REPORT OF THE COMPENSATION COMMITTEE 25
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION Summary Compensation 26 All Other Compensation Table 27 Grants of Plan-Based Awards 28 Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table 28 Employment Agreements 29 Annual Cash Incentives 29 Stock Incentive Plans 30 Outstanding Equity Awards at Fiscal Year End 31 Option Exercises and Stock Vested 33 Nonqualified Deferred Compensation 34 Excess Benefit Plan and Deferred Compensation Plan 34 Potential Payments Upon Termination or Change in Control 35 Executive Pay Ratio 41 PAY VERSUS PERFORMANCE TABLE 41 TRANSACTIONS WITH RELATED PERSONS 46
Security Ownership of Certain Beneficial Owners
Security Ownership of Certain Beneficial Owners 46
Security Ownership of Executive Officers and Directors
Security Ownership of Executive Officers and Directors 47 DELINQUENT SECTION 16(A) REPORTS 48 CLAWBACK POLICY 48 ANTI-HEDGING POLICY 48 PROPOSAL 2 – RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 48 Recommendation 49 REPORT OF THE AUDIT COMMITTEE 49 PRINCIPAL ACCOUNTANT FEES AND SERVICES 50 PROPOSAL 3 – ADVISORY VOTE ON EXECUTIVE COMPENSATION 51 Recommendation 51 PROPOSAL 4 – SHAREHOLDER OPPORTUNITY TO VOTE ON EXCESSIVE GOLDEN PARACHUTES 52 Recommendation 53 PROPOSALS FOR THE NEXT ANNUAL MEETING Proposals to be Included in Our 2025 Proxy Statement 55 Stockholder Proposals Regarding Nominations or Other Business at the 2024 Annual Meeting 55 IMPORTANT NOTICE REGARDING AVAILABILITY OF PROXY MATERIALS FOR ANNUAL MEETING 56 OTHER INFORMATION 56 EXHIBIT A: Executive Officer Cash Severance Policy 58 2023 Perform anc e The following chart summarizes both Chemed's Adjusted EPS and stock price performance since 2003. 1 2 PROXY STATEMENT This Proxy Statement and the accompanying proxy card are furnished in connection with the solicitation by the Board of Directors (the "Board" or the "Board of Directors") of Chemed Corporation (the "Company" or "Chemed") of proxies to be used at the Annual Meeting of Stockholders of the Company to be held at 11:00 a.m. Eastern Time on May 20, 2024 at The Queen City Club, 331 East Fourth Street, Cincinnati, Ohio (the "Annual Meeting"), and any adjournments or postponements thereof. The Company's mailing address is Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726. The approximate date on which this Proxy Statement and the enclosed proxy card are first being given or sent to stockholders is April 8, 2024. The Board unanimously recommends that you vote FOR the election of each of the Board's nominees named on the proxy card accompanying this Proxy Statement. Please read "How to Vote" for more information on how to vote your